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Erratum
In the paper entitled 'Immunohistochemical detection of mul-
tidrug resistance associated P-glycoprotein in tumour and
stromal cells of human cancers' by D. Schlaifer, G. Laurent,
S. Chittal & 8 others, (volume 62, pp. 177-182) there were
errors in Tables I, II and III. Correct versions of these Tables
are shown below:









Carcinoma of unknown origin











Non-small cell lung carcinoma
Non-small cell lung carcinoma
Non-small cell lung carcinoma











































































































































































































































































ap.gp staining: Neo = neoplastic cells, Mac = macrophages. End = endothelial cells. Number of
positive cells: 0 = no positive cell, 1 = <10% positive cells; 2 = 10-75% positive cells, 3 = >75%
positive cells. Intensity of staining: W = weak, M = moderate, S = strong.
'PI Macmillan Press Ltd., 1991 Br. J. Cancer (1991), 63, 164-165ERRATUM 165
Table II Hodgkin's disease, clinical data and results of P-gp staining
P-gp stainingc
Neo Mac End
No Sex-Age Grade Stage Therapya Responseb C219 MRKI6 C219 MRKJ6 C219 MRKJ6
I F-49 3 IVBb MOPPx6 CR 0 0 3S 3S 0 0
ABVDx6
2 M-42 1 IIIAa MOPPx3 CR 0 0 2W 2W 0 0
ABVDx3
3 M-24 2 IIIBb MOPPx3 CR 0 0 2W 2W 0 0
ABVDx3
RT
4 F-18 2 IIIBb MOPPx3 CR 0 0 2W 2W 0 0
ABVDx3
RT
5 M-27 2 IIIBb MOPPx3 CR 0 0 0 0 0 0
ABVDx3
RT
6 M-27 2 IIAb MOPPx3 CR 0 0 0 0 0 0
RT
7 M-61 2 IIIBb MOPPx3 CR 0 0 0 0 0 0
ABVDx3
8 F-30 2 IIAa MOPPx3 CR 0 0 0 0 0 0
RT
9 F-42 2 IVBb MOPPx6 PD 0 0 2M 2M iM IM
ABVDx6
RT
10 M-62 Nd IVBb MOPPx6 PD 0 0 0 0 0 0
ABVDx6
Nd = not determined, CR = complete response, PD = progressive disease. aMOPP = Mustine, Vincristine, Procarbazine, Prednisone.
ABVD = Adriamycin, Bleomycin, Vinblastine, Dacarbazine. RT = Radiotherapy. bResponse evaluated at the end of the chemotherapy. cp1gp
staining: key in Table I.
Table III Non-Hodgkin's lymphomas, clinical data and results of P-gp staining
P-gp stainingc
Therapy" Neo Mac End
No Sex-Age Histologya a b C219 MRKJ6 C219 MRK16 C219 MRK16
I F-59 F no M-BACODx6 0 0 3S 3S 0 0
2 M-67 B no CHOP-Bx6 0 0 0 0 0 0
3 M-69 G no CHOP-Bx4 0 0 2M 2M 0 0
4 F-75 H no CHOP-Bx7 0 0 2M 2M 1W 1W
5 M-50 H no CHOP-Bx8 0 0 2M 2W 0 0
6 M-66 E no CHOP-Bx4 0 0 0 0 1W 1W
7 M-52 H M-BACODx6 CHOP-Bx6 0 0 0 0 0 0
8 F-56 H CHOP-Bx6 M-BACODxl 0 0 2M 2M 0 0
9 M-53 G M-BACODx6 CHOP-Bx4 0 0 2S 2S 2W 2W
10 M-59 E CHOP-Bx6 M-BACODx6 0 0 1M 1W 1M IM
11 F-65 F CHOP-Bx6 M-BACODx9 0 0 IM IM 0 0
12 F-52 C CHOP-Bx7 M-BACODx2 0 0 3S 3S 0 0
13 M-71 C CHOP-Bx6 M-BACODx4 0 0 0 0 0 0
14 F-41 G COPx2 M-BACODx5 0 0 2S 2S 0 0
15 F-55 A COPx2 CHOPx6 0 0 2S 2S 0 0
aHistology was given according to the Working Formulation (Anonymous, 1982): A = lymphocytic lymphoma, B = follicular small cleaved
cell lymphoma, C = follicular small and large cell lymphoma, E = diffuse small cleaved cell lymphoma, F = diffuse mixed lymphoma,
G = diffuse large cell lymphoma, H = immunoblastic lymphoma. 'Therapy (a) before and (b) after the lymph node biopsy studied here. A or
H = adriamycin, B = bleomycin, C = cyclophosphamide, D = dexamethasone, M = methotrexate, 0 = vincristine, P = prednisone. cp-gp
staining: key in Table I.